490 related articles for article (PubMed ID: 31512202)
1. Direct oral anticoagulants: a review on the current role and scope of reversal agents.
Chaudhary R; Sharma T; Garg J; Sukhi A; Bliden K; Tantry U; Turagam M; Lakkireddy D; Gurbel P
J Thromb Thrombolysis; 2020 Feb; 49(2):271-286. PubMed ID: 31512202
[TBL] [Abstract][Full Text] [Related]
2. Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols.
Huisman MV; Fanikos J
Am J Emerg Med; 2016 Nov; 34(11S):46-51. PubMed ID: 27697438
[TBL] [Abstract][Full Text] [Related]
3. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
Tummala R; Kavtaradze A; Gupta A; Ghosh RK
Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
[TBL] [Abstract][Full Text] [Related]
4. Idarucizumab and Factor Xa Reversal Agents: Role in Hospital Guidelines and Protocols.
Huisman MV; Fanikos J
Am J Med; 2016 Nov; 129(11S):S89-S96. PubMed ID: 27569673
[TBL] [Abstract][Full Text] [Related]
5. Reversal agents for direct oral anticoagulants: considerations for hospital physicians and intensivists.
Desai NR; Cornutt D
Hosp Pract (1995); 2019 Aug; 47(3):113-122. PubMed ID: 31317796
[TBL] [Abstract][Full Text] [Related]
6. How can we reverse bleeding in patients on direct oral anticoagulants?
Crowther M; Cuker A
Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
[TBL] [Abstract][Full Text] [Related]
7. Prevention and Treatment of Bleeding with Direct Oral Anticoagulants.
Crawley RM; Anderson RL
Drugs; 2020 Sep; 80(13):1293-1308. PubMed ID: 32691292
[TBL] [Abstract][Full Text] [Related]
8. Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants.
Gómez-Outes A; Alcubilla P; Calvo-Rojas G; Terleira-Fernández AI; Suárez-Gea ML; Lecumberri R; Vargas-Castrillón E
J Am Coll Cardiol; 2021 Jun; 77(24):2987-3001. PubMed ID: 34140101
[TBL] [Abstract][Full Text] [Related]
9. Current Strategies for the Management of Bleeding Associated with Direct Oral Anticoagulants and a Review of Investigational Reversal Agents.
Kaide CG; Gulseth MP
J Emerg Med; 2020 Feb; 58(2):217-233. PubMed ID: 31831187
[TBL] [Abstract][Full Text] [Related]
10. Reversal of Direct Oral Anticoagulants: Current Status and Future Directions.
Weitz JI
Semin Respir Crit Care Med; 2017 Feb; 38(1):40-50. PubMed ID: 28208197
[TBL] [Abstract][Full Text] [Related]
11. Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding.
Grottke O; Afshari A; Ahmed A; Arnaoutoglou E; Bolliger D; Fenger-Eriksen C; von Heymann C
Eur J Anaesthesiol; 2024 May; 41(5):327-350. PubMed ID: 38567679
[TBL] [Abstract][Full Text] [Related]
12. Reversal of direct oral anticoagulants.
Almegren M
Vasc Health Risk Manag; 2017; 13():287-292. PubMed ID: 28769570
[TBL] [Abstract][Full Text] [Related]
13. Reversing the anticoagulation effects of dabigatran.
Dager WE; Banares L
Hosp Pract (1995); 2017 Apr; 45(2):29-38. PubMed ID: 28335637
[TBL] [Abstract][Full Text] [Related]
14. Reversal agents for non-vitamin K antagonist oral anticoagulants.
Levy JH; Douketis J; Weitz JI
Nat Rev Cardiol; 2018 May; 15(5):273-281. PubMed ID: 29345686
[TBL] [Abstract][Full Text] [Related]
15. A review of oral anticoagulants, old and new, in major bleeding and the need for urgent surgery.
Milling TJ; Ziebell CM
Trends Cardiovasc Med; 2020 Feb; 30(2):86-90. PubMed ID: 30952383
[TBL] [Abstract][Full Text] [Related]
16. Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs).
Hussain SS; Tyroch AH; Mukherjee D
Cardiovasc Hematol Agents Med Chem; 2017; 14(2):76-81. PubMed ID: 27215215
[TBL] [Abstract][Full Text] [Related]
17. Reversal of direct oral anticoagulants: a practical approach.
Shih AW; Crowther MA
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):612-619. PubMed ID: 27913536
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures.
Levy JH
Am J Med; 2016 Nov; 129(11S):S47-S53. PubMed ID: 27569675
[TBL] [Abstract][Full Text] [Related]
19. Managing reversal of direct oral anticoagulants in emergency situations. Anticoagulation Education Task Force White Paper.
Ageno W; Büller HR; Falanga A; Hacke W; Hendriks J; Lobban T; Merino J; Milojevic IS; Moya F; van der Worp HB; Randall G; Tsioufis K; Verhamme P; Camm AJ
Thromb Haemost; 2016 Nov; 116(6):1003-1010. PubMed ID: 27488232
[TBL] [Abstract][Full Text] [Related]
20. Reversal strategies in patients treated with direct oral anticoagulants.
Gressenberger P
Vasa; 2019 Aug; 48(5):389-392. PubMed ID: 30719950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
